GAPDH and neoplasm: Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is another glycolytic enzyme that was found significantly upregulated in TMD myalgia patients and, like PGK1, is overexpressed in various malignancies and correlates positively with tumor progression [28,29].